EZH2 is a prognostic factor associated with tumor stemness and immune infiltration in skull base chordoma

• Qian Liu,
• Mingxuan Li,
• Yujia Xiong,
• Yutao Shen,
• Tianshun Ma,
• Tianhao Zhang,
• Xiaohong R. Yang,
• Yazhuo Zhang,
• Jiwei Bai

Affiliations

Qian Liu

Beijing Neurosurgical Institute, Capital Medical University, Beijing 100070, China; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China

Mingxuan Li

Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China

Yujia Xiong

Beijing Neurosurgical Institute, Capital Medical University, Beijing 100070, China

Yutao Shen

Beijing Neurosurgical Institute, Capital Medical University, Beijing 100070, China

Tianshun Ma

Beijing Neurosurgical Institute, Capital Medical University, Beijing 100070, China

Tianhao Zhang

Beijing Neurosurgical Institute, Capital Medical University, Beijing 100070, China

Xiaohong R. Yang

Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD 20892, USA

Yazhuo Zhang

Beijing Neurosurgical Institute, Capital Medical University, Beijing 100070, China; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China; Corresponding author. Beijing Neurosurgical Institute, Capital Medical University, Beijing 100070, China.

Jiwei Bai

Beijing Neurosurgical Institute, Capital Medical University, Beijing 100070, China; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China; Corresponding author. Beijing Neurosurgical Institute, Capital Medical University, Beijing 100070, China.